Edwards Lifesciences Corp. (EW)
84.37
-2.40
(-2.77%)
USD |
NYSE |
Sep 11, 16:00
84.42
+0.05
(+0.06%)
After-Hours: 20:00
Edwards Lifesciences Enterprise Value : 45.20B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 45.20B |
| September 10, 2026 | 46.59B |
| September 09, 2026 | 46.25B |
| September 08, 2026 | 46.56B |
| September 04, 2026 | 48.39B |
| September 03, 2026 | 48.32B |
| September 02, 2026 | 48.92B |
| September 01, 2026 | 48.88B |
| August 31, 2026 | 48.88B |
| August 28, 2026 | 48.57B |
| August 27, 2026 | 48.42B |
| August 26, 2026 | 48.90B |
| August 25, 2026 | 48.95B |
| August 24, 2026 | 48.74B |
| August 21, 2026 | 48.33B |
| August 20, 2026 | 48.35B |
| August 19, 2026 | 49.76B |
| August 18, 2026 | 49.02B |
| August 17, 2026 | 48.92B |
| August 14, 2026 | 49.37B |
| August 13, 2026 | 49.93B |
| August 12, 2026 | 50.21B |
| August 11, 2026 | 50.56B |
| August 10, 2026 | 49.62B |
| August 07, 2026 | 48.29B |
| Date | Value |
|---|---|
| August 06, 2026 | 48.06B |
| August 05, 2026 | 47.86B |
| August 04, 2026 | 48.22B |
| August 03, 2026 | 47.77B |
| July 31, 2026 | 46.18B |
| July 30, 2026 | 46.67B |
| July 29, 2026 | 46.01B |
| July 28, 2026 | 44.81B |
| July 27, 2026 | 44.44B |
| July 24, 2026 | 44.20B |
| July 23, 2026 | 44.89B |
| July 22, 2026 | 45.20B |
| July 21, 2026 | 45.31B |
| July 20, 2026 | 45.57B |
| July 17, 2026 | 45.99B |
| July 16, 2026 | 47.20B |
| July 15, 2026 | 46.88B |
| July 14, 2026 | 48.50B |
| July 13, 2026 | 49.48B |
| July 10, 2026 | 49.72B |
| July 09, 2026 | 49.22B |
| July 08, 2026 | 50.55B |
| July 07, 2026 | 51.23B |
| July 06, 2026 | 51.44B |
| July 02, 2026 | 50.97B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intuitive Surgical, Inc. | 125.52B |
| Stryker Corp. | 117.67B |
| Abbott Laboratories | 204.07B |
| Zimmer Biomet Holdings, Inc. | 24.90B |
| Solventum Corp. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 241.40M |
| Revenue (Quarterly) | 1.741B |
| Total Expenses (Quarterly) | 1.499B |
| EPS Diluted (Quarterly) | 0.4188 |
| Gross Profit Margin (Quarterly) | 78.09% |
| Profit Margin (Quarterly) | 13.87% |
| Earnings Yield | 2.00% |
| Operating Earnings Yield | 3.79% |
| Normalized Earnings Yield | 2.808 |